Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The main aim of this study was to investigate the first trimester maternal serum secreted frizzle-related protein-5 (Sfrp-5) levels and to evaluate the predictive value on the subsequently developed gestational diabetes mellitus (GDM). METHODS: A total of 40 pregnant women who subsequently developed GDM and 44 age- and pre-pregnancy BMI-matched healthy pregnant women were enrolled in this prospective case-control study. First trimester serum Sfrp-5 levels were evaluated to determine if there is an association with the onset of GDM, by using logistic regression analysis. RESULTS: Decreased first trimester serum Sfrp-5 levels (OR = 14.332, 95%CI: 4.166-49.301, p < 0.001) were found to be significantly associated with the increased risk of GDM. There were no statistically significant differences in serum Sfrp-5 levels between the diet- and insulin-treated GDM groups and also serum Sfrp-5 levels were not found to be predictive for adverse perinatal outcomes (p > 0.05). CONCLUSIONS: Decreased first trimester serum Sfrp-5 levels are significantly associated with the increased risk of GDM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies suggest that biomarkers such as CD59 (287) or serum secreted frizzlerelated protein-5 (288) may be useful in early identification of women in whom GDM will be identified later in pregnancy.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [288]
Citations
Cites
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · cited 1×
“However, these adverse consequences are not restricted only in the gestational period but rather affecting the future life of both fetus and mother as they are at increased risk of developing type II diabetes, obesity and cardiovascular disease [3,4].”
BackgroundDiagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Lifestyle modification and insulin treatment are the major components of primary approach to reduce adverse outcomes when GDM is diagnosed [5,6] and also early intervention is important as”
BackgroundGestational Diabetes Mellitus: Risks and Management during and after Pregnancy
Buchanan, T. A., Xiang, A. H., & Page, K. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.96 · Cited by 718 · cited 1×
“However, these adverse consequences are not restricted only in the gestational period but rather affecting the future life of both fetus and mother as they are at increased risk of developing type II diabetes, obesity and cardiovascular disease [3,4].”
BackgroundGestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677 · cited 1×
“Lifestyle modification and insulin treatment are the major components of primary approach to reduce adverse outcomes when GDM is diagnosed [5,6] and also early intervention is important as”
Background(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-461 · Cited by 663
Requirement of Prorenin Receptor and Vacuolar H + -ATPase–Mediated Acidification for Wnt Signaling
Cruciat, C.-M., Ohkawara, B., Acebron, S. P., Karaulanov, E., Reinhard, C., Ingelfinger, D., Boutros, M., & Niehrs, C. (2010) · Science · doi:10.1126/science.1179802 · Cited by 516
Jovanovic, L. (2001) · JAMA · doi:10.1001/jama.286.20.2516 · Cited by 399
Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): Randomised control trial
Walsh, J. M., McGowan, C. A., Mahony, R., Foley, M. E., & McAuliffe, F. M. (2012) · BMJ · doi:10.1136/bmj.e5605 · Cited by 341 · cited 1×
“showed, even only low glycemic index diet has a significant positive effect on maternal glucose intolerance [7].”
BackgroundFirst-Trimester C-Reactive Protein and Subsequent Gestational Diabetes
Wolf, M., Sandler, L., Hsu, K., Vossen-Smirnakis, K., Ecker, J. L., & Thadhani, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.819 · Cited by 251 · cited 1×
“Increased fasting plasma glucose and C-reactive protein levels were suggested to be predictive for GDM in early pregnancy [8,9].”
Background
Research works printed but not linked: 1
- Almario RU, 2015, Horm Metab Res, 47, 152
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 205
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0
Ruszała, M., Pilszyk, A., Niebrzydowska-Tatus, M., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084364 · Cited by 44
Inthavong, S., Jatavan, P., & Tongsong, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111666 · Cited by 37
“[69].”
Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions
Parrettini, S., Cavallo, M., Gaggia, F., Calafiore, R., & Luca, G. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200505214555 · Cited by 29
Metadata
- Authors
- Oztas, E., Ozler, S., Ersoy, E., Ersoy, A. O., Tokmak, A., Ergin, M., Uygur, D., & Danisman, N.
- Affiliations
- Department of Obstetrics and Gynecology, Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey, and
- Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi (TR)
- Ankara Yıldırım Beyazıt University (TR)
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2015-06-23
- Volume
- 29
- Issue
- 9
- Pages
- 1515-1519
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W1868907702
- Semantic Scholar
- e0dd918cbdf7da3bad0ca8162784836b8b5d3cdb
- Cited by
- 16
- References
- 31
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 2 · 2016: 2
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- AYBU AVESIS (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, SFRP5, first trimester, maternal serum biomarkers, GDM prediction, risk factors, perinatal outcomes, insulin therapy, dietary therapy
- MeSH terms
- Secreted Frizzled-Related Proteins, Adult, Eye Proteins, Female, Humans, Membrane Proteins, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, First, Epidemiologic Studies, Diabetes, Gestational, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels. https://app.cochat.ai/papers/10.3109/14767058.2015.1052399
- The paper
- Oztas, E., Ozler, S., Ersoy, E., Ersoy, A. O., Tokmak, A., Ergin, M., Uygur, D., & Danisman, N. (2016). Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.3109/14767058.2015.1052399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.